2017 Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
09 2019
Historique:
received: 18 02 2019
revised: 01 04 2019
accepted: 25 05 2019
pubmed: 31 5 2019
medline: 1 4 2020
entrez: 1 6 2019
Statut: ppublish

Résumé

The French Renal Epidemiology and Information Network (REIN) registry started in 2002 with the goal to provide a tool to evaluate renal replacement therapy (RRT) practices and outcomes, to provide data for research and to support public health decisions related to end-stage renal disease ESRD. This summary presents the incidence and prevalence of RRT including kidney transplantation and wait-listing activity in 2017, and patients' survival and trends over 5 years. In 2017, 11 543 patients started RRT for ESRD, that is, incidence of 172 pmp. Between 2012 and 2017, the incidence of RRT increased by 1% per year [CI 95% (0.0; +2.0)]. On 31 December 2017, 87 275 patients were receiving RRT, that is, prevalence of 1294 pmp, 55% on dialysis, 45% with a functioning transplant. In 2017, 3782 kidney transplantations have been performed including 16% from a living donor, 13% being retransplantations and 15% pre-emptive transplantations. The median time on the waiting list was 19.7 months when only taking into account active waiting periods on the list. In 2017, 5280 new patients were registered on the renal transplant waiting list (i.e. 78.7 pmp). The number of patients considered as 'inactive' represented 45% of the patients on the list.

Identifiants

pubmed: 31148236
doi: 10.1111/tri.13466
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

892-902

Informations de copyright

© 2019 Steunstichting ESOT.

Références

Couchoud C, Stengel B, Landais P, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21: 411.
Couchoud C, Lassalle M, Jacquelinet C. REIN Annual report 2016. Agence de la biomédecine, 2017.
INSEE. The National Institute of Statistics and Economic Studies. https://wwwinseefr/en/accueil.
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335.
National Cancer Institute. Joinpoint Trend Analysis Software. https://surveillancecancergov/joinpoint/.
Chevreul K, Durand-Zaleski I, Bahrami SB, Hernandez-Quevedo C, Mladovsky P. France: health system review. Health Syst Transit 2010; 12: 1, xxi-xxii.
Helve J, Kramer A, Abad-Diez JM, et al. Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2018.
Michel A, Pladys A, Bayat S, Couchoud C, Hannedouche T, Vigneau C. Deleterious effects of dialysis emergency start, insights from the French REIN registry. BMC Nephrol 2018; 19: 233.
Alencar de Pinho N, Coscas R, Metzger M, et al. Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study. BMC Nephrol 2017; 18: 74.
Kramer A, Pippias M, Noordzij M, et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary. Clin Kidney J 2018; 11: 108.
Pippias M, Jager KJ, Kramer A, et al. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2016; 31: 831.
Foucher Y, Le Borgne F, Legendre C, et al. Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study. Nephrol Dial Transplant 2018.
Prezelin-Reydit M, Combe C, Harambat J, et al. Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database. Nephrol Dial Transplant 2019; 34: 538.
Legeai C, Andrianasolo RM, Moranne O, et al. Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy. Am J Transplant 2018; 18:2695.
Bechade C, Lobbedez T, Ivarsen P, Povlsen JV. Assisted peritoneal dialysis for older people with end-stage renal disease: the French and Danish experience. Perit Dial Int 2015; 35: 663.
Societe Francophone de Nephrologie Dialyse Et T. [Report on chronic dialysis in France in 2016]. Nephrol Ther 2017; 13: 105.
Dusseux E, Albano L, Fafin C, et al. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int 2015; 88: 121.
Pladys A, Morival C, Couchoud C, et al. Outcome-dependent geographic and individual variations in the access to renal transplantation in incident dialysed patients: a French nationwide cohort study. Transpl Int 2018; 32: 369.
Marrero WJ, Naik AS, Friedewald JJ, et al. Predictors of deceased donor kidney discard in the United States. Transplantation 2017; 101: 1690.
Hogan J, Savoye E, Macher MA, et al. Rapid access to renal transplant waiting list in children: impact of patient and centre characteristics in France. Nephrol Dial Transplant 2014; 29: 1973.

Auteurs

Mathilde Lassalle (M)

REIN Registry, Agence de la biomédecine, Saint Denis La Plaine Cedex, France.

Elisabeth Monnet (E)

Unité Epidémiologie- Santé Publique, CIC INSERM 1431 CHRU Besançon, Besançon, France.

Carole Ayav (C)

CIC 1433 Epidémiologie Clinique, Inserm, CHRU, Université de Lorraine, CHRU de Nancy - Hôpitaux de Brabois, Nancy, France.

Julien Hogan (J)

Hôpital Robert Debré, Paris, France.

Olivier Moranne (O)

Hopital Caremau, CHU Nîmes, Institut Universitaire de Recherche Clinique - EA2415, Université de Montpellier, Nîmes, France.

Cécile Couchoud (C)

REIN Registry, Agence de la biomédecine, Saint Denis La Plaine Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH